Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

RESMED INC.

(RMD)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settoreAnalisi MarketScreener
Notizie in altre lingue su RESMED INC.
21/01INSIDER SELL: Resmed
13/01TODAY ON WALL STREET: Time for a new chapter?
13/01ANALYST RECOMMENDATIONS: AbbVie, Asos, Block, Dow, Metlife...
11/01INSIDER SELL: Resmed
06/01ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022
03/01ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
2021ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscrip..
2021NORTH AMERICAN MORNING BRIEFING: Dow Futures Dip -2-
2021TODAY ON WALL STREET: Investors buy the dip
2021ANALYST RECOMMENDATIONS: Alibaba, Cigna, McDonald's, Oracle, Reckitt...
2021INSIDER SELL: Resmed
2021INSIDER SELL: Resmed
2021NORTH AMERICAN MORNING BRIEFING: Dow Futures Jump -3-
2021INSIDER SELL: Resmed
2021Australia shares rebound, gain 1% as investors absorb Omicron shock
2021RESMED INC: Submission of Matters to a Vote of Security Holders (form 8-K)
2021ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directo..
2021ResMed Inc. Announces Board Appointments
2021INSIDER SELL: Resmed
2021Thinking about trading options or stock in Riot Blockchain, AMC Entertainment, ResMed, ..
2021INSIDER SELL: Resmed
2021Australia shares slip as heavy losses in banks offset strong miners
2021INSIDER SELL: Resmed
2021ResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference
2021Will Shortages Limit Upside For ResMed?
2021Citi rates RMD as Neutral
2021Morgans rates RMD as Add
2021Macquarie rates RMD as Neutral
2021Morgan Stanley rates RMD as Equal-weight
2021Tranche Update on ResMed Inc.'s Equity Buyback Plan announced on February 27, 2014.
2021ResMed Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021
2021Resmed Fiscal Q1 Jumps 14% on Higher Demand for Sleep, Respiratory Care Products; Share..
2021ResMed Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Board Maintains Quarterly Cash Divide..
2021RESMED: Fiscal Q1 Earnings Snapshot
20211Q22 Earnings Presentation
2021Corporate & Investor Presentation
2021ResMed to Seek Acquisitions
2021ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022 - Form 8-K
2021RESMED INC: Results of Operations and Financial Condition, Other Events, Financial Statem..
2021ResMed Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021
2021ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022
2021Resmed Inc. Declares Quarterly Cash Dividend, Payable on December 16, 2021
2021EARNINGS REACTION HISTORY: Resmed Inc, 71.4% Follow-Through Indicator, 7.9% Sensitive
2021INSIDER SELL: Resmed
2021INSIDER SELL: Resmed
2021RESMED: to Report First Quarter Fiscal 2022 Earnings on October 28, 2021
2021RESMED: Change in Directors or Principal Officers (form 8-K/A)
2021INSIDER SELL: Resmed
2021RESMED: Acquires Ectosense, a Leader in Connected Home Sleep Testing
2021ResMed Inc. acquired Ectosense N.V.
2021RESMED INC.(ASX: RMD) added to S&P/ASX 50 Index
2021INSIDER SELL: ResMed
2021INSIDER SELL: Resmed
2021RESMED: As Approved and Adopted by Board Resolution (Form 8-K)
2021RESMED INC: Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial St..
2021RESMED: Virtual Investor Day
2021RESMED: Announces Participation in the Bank of America Global Healthcare Conference
2021RESMED: People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Suppor..
2021INSIDER SELL: Resmed
2021INSIDER SELL: Resmed
2021RESMED: PAP-linked Survival Rate, New COPD Prevalence, Benefits of Telemonitoring Ventila..
2021RESMED: Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Confe..
2021RESMED INC: Change in Directors or Principal Officers (form 8-K)
2021RESMED: Announces SaaS Leadership Change
2021ResMed Announces management changes
2021SUPERMOON CAPITAL: Launches with World's First Fund Focused on Sleep
2021RESMED: 2021 Annual Report (PDF 1.55 MB)
2021Tranche Update on ResMed Inc.'s Equity Buyback Plan announced on February 27, 2014.
2021RESMED: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERAT..
2021RESMED: Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatmen..
2021ResMed Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatme..
2021INSIDER TRENDS: Insider Extends Selling Trend at ResMed
2021TODAY ON WALL STREET: Q2 Earnings season was a good vintage
2021ANALYST RECOMMENDATIONS: AMC, AMD, Greggs, Roku, Tesla...
2021RESMED: Credit Suisse rates RMD as Outperform
1  2  3  4  5  6  7  8  9  10Pross.
Prossimo evento su RESMED INC.
27/01/22